Product Information
ARNUITY ELLIPTA 200 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $8.9002 per EA under NDC 00173087614. Its NADAC has been published 114 times since Jun 19, 2024.
FDA first approved this application on Aug 20, 2014.
Strength
200 ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173087614
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
FLUTICASONE FUROATEApproval Type
New Drug (NDA)
FDA Application
NDA205625FDA Approved
8/20/2014
On Market Since
8/20/2014
Pharmacological Classes
Price Statistics
The NADAC for ARNUITY ELLIPTA 200 MCG INH has been published 114 times since Jun 19, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9002 per EA |
|---|---|
| All-time high | $8.9624 (Aug 14, 2024) |
| All-time low | $8.8921 (Dec 17, 2025) |
| 52-week high | $8.9199 |
| 52-week low | $8.8921 |
| Median price | $8.9204 |
| Average price | $8.9190 |
| Largest weekly change | -0.2% (Sep 18, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ARNUITY ELLIPTA 200 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for ARNUITY ELLIPTA 200 MCG INH, manufactured by GlaxoSmithKline LLC, is $8.9002 per EA (NDC 00173087614), effective Aug 19, 2026.
How has the price of ARNUITY ELLIPTA 200 MCG INH changed over time?
Over the history we have for it, the NADAC for ARNUITY ELLIPTA 200 MCG INH has held within roughly two percent of its current level. It has been tracked across 114 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for ARNUITY ELLIPTA 200 MCG INH?
Since Jun 19, 2024, the NADAC for ARNUITY ELLIPTA 200 MCG INH has ranged from a low of $8.8921 (Dec 17, 2025) to a high of $8.9624 (Aug 14, 2024), with a median of $8.9204 per EA.
Are there cheaper alternatives to ARNUITY ELLIPTA 200 MCG INH?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE ELLIPTA 200 MCG INH, is $5.6931 per EA — about 36% below ARNUITY ELLIPTA 200 MCG INH.
Who manufactures ARNUITY ELLIPTA 200 MCG INH?
ARNUITY ELLIPTA 200 MCG INH (NDC 00173087614) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.